___

•  Andaç A, Yaşayan G, Alarçin E, Okuyan B, Şahbaz S (2015) Eczane Mesul Müdürlerinin Magistral İlaç Hazırlama ile ilgili Bilgi ve Tutumlarının Değerlendirilmesi. Marmara Pharmaceutical Journal 19: 283-289. DOI: 10.12991/mpj.201519399879 [CrossRef]  Baytop T (1997) Laboratuvardan Fabrikaya: Türkiye’de İlaç Sanayii (1833-1954). Görsel Sanatlar Matbaacılık, İstanbul.  Brion F, Nunn A, Rieutord A (2003) Extemporaneous (magistral) preparation of oral medicines for children in European hospitals. Acta Paediatrica 92(4): 486-490. https://doi.org/10.1111/j.1651-2227.2003.tb00583.x [CrossRef]  Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Anker J (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. Bmj 320(7227): 79-82. https://doi.org/10.1136/bmj.320.7227.79 [CrossRef]  Emmerton L, Marriott J, Bessell T, Nissen L, Dean L (2005) Pharmacists and Prescribing Rights: Review of International Developments. J Pharm Pharmaceut Sci 8(2): 217-225. DOI 10.1007/s11096-015-0226-9 [CrossRef]  Ergün H, Berk B, Uludağ M, Diler İ, Demir ED, Gümüşel B (2010) Türkiye’de eczanelerde hazırlanan (magistral) nitrogliserin merhemlerinin içerik ve sunum özellikleri yönünden değerlendirilmesi. Marmara Eczacılık Dergisi 14: 130-135. DOI: 10.12991/201014448 [CrossRef]  Garcia MC, Manzo RH, Jimenez-Kairuz AF (2015) Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients. Tropical Medicine and International Health 20(7): 864–870. https://doi.org/10.1111/tmi.12508 [CrossRef]  Geçgil Ş (1991). Farmasötik Teknolojiye Başlangıç. Cihan Matbaacılık, İstanbul.  Gubara OA, Gubara TOA, Ayoub MO, Shayoub MEA, Hassan AME, Abd Alla Ah MEA, Ali MEA, Eldim Mahmmoud AN (2016) Extemporaneous Compounding: Attitudes of Community Pharmacists at Khartoum City. World Journal of Pharmaceutical Research 5(6): 119-140. DOI: 10.20959/wjpr20166-6287 [CrossRef]  Gubara OA, Shayoub MELA, Haj Elamin AE, Ayoub MO, Tumsah MAR, Masaad AMA, Shyoub AM (2018) Attitudes and Opinion of Hospital Pharmacists Towards Extemporaneous Compounding and Related Issues in Khartoum City: Part II. World Journal of Pharmaceutical Research 7(8): 1-29. DOI: 10.20959/wjpr20188-11834. [CrossRef]  Ilgın Ruhi H (2010) Meme Kanserinde Farmakogenetik. Turkiye Klinikleri Journal of Medical Sciences 30(3): 16-21. [CrossRef]  Kairuz T, Chhim S, Hasan F, Kumar K, Lal A, Patel R, Garg S (2007) Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey. The New Zealand Medıcal Journal 120(1251): 1-9. [CrossRef]  Kairuz T, Gargiulo D, Bunt C, Garg S (2007) Quality, Safety and Efficacy in the ‘Off-Label’ Use of Medicines. Current Drug Safety 2(1): 89-95. https://doi.org/10.2174/157488607779315471 [CrossRef]  Kristina S, Wiedyaningsih C, Widyakusuma N, Aditama H (2017) Extemporaneous compounding practice by pharmacists: a systematic review. International Journal of Pharmacy and Pharmaceutical Sciences 9(2): 42-46. https://doi.org/10.22159/ijpps.2017v9i2.15681 [CrossRef]  Leal AS, de BC Menezes MA, Dalmázio I, Sepe FP, Gomes CBT, Santana AS, Cunha LH, Jaćimović R (2012) Quality Control of Formulated Medicines. In Latest Research into Quality Control. InTech : 227-242. http://dx.doi.org/10.5772/51459 [CrossRef]